Literature DB >> 6197535

Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody.

G H Cohen, B Dietzschold, M Ponce de Leon, D Long, E Golub, A Varrichio, L Pereira, R J Eisenberg.   

Abstract

An antigenic determinant capable of inducing type-common herpes simplex virus (HSV)-neutralizing antibodies has been located on glycoprotein D (gD) of HSV type 1 (HSV-1). A peptide of 16 amino acids corresponding to residues 8 to 23 of the mature glycoprotein (residues 33 to 48 of the predicted gD-1 sequence) was synthesized. This peptide reacted with an anti-gD monoclonal antibody (group VII) previously shown to neutralize the infectivity of HSV-1 and HSV-2. The peptide was also recognized by polyclonal antibodies prepared against purified gD-1 but was less reactive with anti-gD-2 sera. Sera from animals immunized with the synthetic peptide reacted with native gD and neutralized both HSV-1 and HSV-2.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6197535      PMCID: PMC255430     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

2.  Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins.

Authors:  P Y Chou; G D Fasman
Journal:  Biochemistry       Date:  1974-01-15       Impact factor: 3.162

3.  Prediction of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Biochemistry       Date:  1974-01-15       Impact factor: 3.162

4.  Synthetic vaccines--a dream or reality.

Authors:  R Arnon
Journal:  Adv Exp Med Biol       Date:  1972       Impact factor: 2.622

5.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

6.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

7.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

8.  Direct microsequence analysis of polypeptides using an improved sequenator, a nonprotein carrier (polybrene), and high pressure liquid chromatography.

Authors:  M W Hunkapiller; L E Hood
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

9.  Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein.

Authors:  G H Cohen; M Katze; C Hydrean-Stern; R J Eisenberg
Journal:  J Virol       Date:  1978-07       Impact factor: 5.103

10.  New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates.

Authors:  F T Liu; M Zinnecker; T Hamaoka; D H Katz
Journal:  Biochemistry       Date:  1979-02-20       Impact factor: 3.162

View more
  96 in total

1.  Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.

Authors:  J C Whitbeck; C Peng; H Lou; R Xu; S H Willis; M Ponce de Leon; T Peng; A V Nicola; R I Montgomery; M S Warner; A M Soulika; L A Spruce; W T Moore; J D Lambris; P G Spear; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Mapping of B-cell epitopes on the polypeptide chain of the Epstein-Barr virus major envelope glycoprotein and candidate vaccine molecule gp340.

Authors:  R J Pither; C X Zhang; C Shiels; J Tarlton; S Finerty; A J Morgan
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

3.  The molecular organization of the lysostaphin gene and its sequences repeated in tandem.

Authors:  P Heinrich; R Rosenstein; M Böhmer; P Sonner; F Götz
Journal:  Mol Gen Genet       Date:  1987-10

4.  Production of a recombinant monoclonal antibody to Herpes Simplex Virus glycoprotein D for immunoaffinity purification of tagged proteins.

Authors:  Sara M O'Rourke; Bin Yu; Javier F Morales; Chelsea M Didinger; David L Alexander; Christopher Vollmers; Phillip W Berman
Journal:  J Immunol Methods       Date:  2018-11-28       Impact factor: 2.303

5.  Potential nectin-1 binding site on herpes simplex virus glycoprotein d.

Authors:  Sarah A Connolly; Daniel J Landsburg; Andrea Carfi; J Charles Whitbeck; Yi Zuo; Don C Wiley; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Characterization of a recombinant herpes simplex virus which expresses a glycoprotein D lacking asparagine-linked oligosaccharides.

Authors:  D L Sodora; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D.

Authors:  D L Sodora; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies.

Authors:  B Pfeiffer; Z N Berneman; F Neipel; C K Chang; S Tirwatnapong; B Chandran
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

Review 10.  The challenge of developing a herpes simplex virus 2 vaccine.

Authors:  Lesia K Dropulic; Jeffrey I Cohen
Journal:  Expert Rev Vaccines       Date:  2012-12       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.